Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience

Despite the fact that cardiovascular disease (CVD) is the number 1 cause of death globally, investment in drug development and new drug approvals for CVD are precipitously declining. In contrast, the trajectory of both investment in development as well as new drug approvals for oncology have been in...

Descripción completa

Detalles Bibliográficos
Autores principales: Khakoo, Aarif Y., Yurgin, Nicole R., Eisenberg, Paul R., Fonarow, Gregg C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
TRANSLATIONAL PERSPECTIVE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488739/
https://www.ncbi.nlm.nih.gov/pubmed/31061928
http://dx.doi.org/10.1016/j.jacbts.2019.01.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488739/
https://www.ncbi.nlm.nih.gov/pubmed/31061928
http://dx.doi.org/10.1016/j.jacbts.2019.01.011

Ejemplares similares